- Home
- KFII vs EHAB Comparison
KFII vs EHAB Comparison
Compare KFII & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFII
- EHAB
- Stock Information
- Founded
- KFII 2024
- EHAB 2014
- Country
- KFII United States
- EHAB United States
- Employees
- KFII N/A
- EHAB N/A
- Industry
- KFII
- EHAB Hospital/Nursing Management
- Sector
- KFII
- EHAB Health Care
- Exchange
- KFII NYSE
- EHAB Nasdaq
- Market Cap
- KFII 393.3M
- EHAB 401.6M
- IPO Year
- KFII 2025
- EHAB N/A
- Fundamental
- Price
- KFII $10.06
- EHAB $10.39
- Analyst Decision
- KFII
- EHAB Hold
- Analyst Count
- KFII 0
- EHAB 3
- Target Price
- KFII N/A
- EHAB $8.50
- AVG Volume (30 Days)
- KFII 40.2K
- EHAB 440.6K
- Earning Date
- KFII 01-01-0001
- EHAB 05-07-2025
- Dividend Yield
- KFII N/A
- EHAB N/A
- EPS Growth
- KFII N/A
- EHAB N/A
- EPS
- KFII N/A
- EHAB N/A
- Revenue
- KFII N/A
- EHAB $1,032,300,000.00
- Revenue This Year
- KFII N/A
- EHAB $4.66
- Revenue Next Year
- KFII N/A
- EHAB $4.99
- P/E Ratio
- KFII N/A
- EHAB N/A
- Revenue Growth
- KFII N/A
- EHAB N/A
- 52 Week Low
- KFII $9.90
- EHAB $6.85
- 52 Week High
- KFII $10.14
- EHAB $10.79
- Technical
- Relative Strength Index (RSI)
- KFII N/A
- EHAB 65.48
- Support Level
- KFII N/A
- EHAB $10.30
- Resistance Level
- KFII N/A
- EHAB $10.62
- Average True Range (ATR)
- KFII 0.00
- EHAB 0.25
- MACD
- KFII 0.00
- EHAB -0.05
- Stochastic Oscillator
- KFII 0.00
- EHAB 42.96
About KFII K&F GROWTH ACQUISITION CORP II
K&F Growth Acquisition Corp II is a special purpose acquisition company.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.